Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: Protocol

BACKGROUND: Warfarin and similar vitamin K antagonists have been the standard therapy for patients with mechanical or biological valve prosthesis and atrial fibrillation (AF). Even with the appropriate use of therapy, some studies have reported that there is a high incidence of thromboembolic events...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Duraes, Andre Rodrigues, Roriz, Pollianna DS, Bulhoes, Fabio V, Nunes, Bianca DA, Muniz, Juliana QV, Neto, Italvar NDCR, Fernandes, Andre MS, Reis, Francisco JFBD, Camara, Edmundo JN, Junior, Erenaldo DSR, Segundo, Deusdeth TS, Silva, Felipe Pinho E Albuquerque, Aras, Roque
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: JMIR Publications Inc. 2014
Θέματα:
Protocol
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4004148/
https://ncbi.nlm.nih.gov/pubmed/24691436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/resprot.3014
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια